The long-acting HIV prevention medication cabotegravir led to an estimated 66% lower HIV incidence versus oral tenofovir/emtricitabine (TDF/FTC), Read More
More Good News for HIV PrEP Injectable
Reading Time: < 1 minute
The long-acting HIV prevention medication cabotegravir led to an estimated 66% lower HIV incidence versus oral tenofovir/emtricitabine (TDF/FTC), Read More